Skip to content
Buy This GLP
← Research
Safety

Tirzepatide Ketoacidosis Case Report in a Woman Without Diabetes

One case report describes ketoacidosis after a first tirzepatide injection in a woman without diabetes.

Editorial profile: Neil SandersBuy This GLP Editorial Team5 min read
Tirzepatide case reportPresentation six days after first injectionHospital recovery reported within 48 hours

Digestive symptoms are among the reported side effects of GLP-1 drugs, and persistent vomiting deserves prompt assessment. This case report describes ketoacidosis in a woman without diabetes after her first tirzepatide injection [1].

What clinicians reported

A woman in her early thirties presented six days after her first injection. She had persistent vomiting, upper abdominal pain and fatigue. Testing showed elevated ketones, metabolic acidosis and mildly low blood sugar [1].

She needed hospital treatment and recovered within 48 hours. The authors described reduced food intake as a possible contributor. One report cannot establish how often this happens or prove tirzepatide was the sole cause.

When to seek medical help

The Zepbound label advises prompt contact with a health care provider for persistent vomiting or other symptoms that can lead to dehydration [2]. Severe, persistent abdominal pain needs immediate medical attention.

Frequently asked

Does this report show how often ketoacidosis occurs?
A single report cannot estimate how often it occurs. Persistent vomiting or severe abdominal pain warrants prompt medical attention.

Sources

  1. [1] Sadiq H, et al. (2026). When Weight Loss Turns Dangerous: A Case Report of Tirzepatide-Induced Ketoacidosis in a Non-diabetic Woman Cureus. PMID 42639616
  2. [2] Eli Lilly and Company (2026). Zepbound (tirzepatide) prescribing information DailyMed, U.S. National Library of Medicine. Source

More in Safety